- Study Finds High Rates of Type 1 Diabetes Near Food Swamps
Link to fast food availability suggests environment may influence type 1 diabetes rates... - Judgment Calls: Hirsutism Guideline Counsels Patient Guidance
According to a new treatment guideline from the Endocrine Society, endocrinologists should base treatment of hirsutism on the distress and perceptions of the patient, not their opinion of its severity. - Androgen Receptor Signaling Linked to PCOS Phenotypes
- Canagliflozin Demonstrated Significant Renal Protective Benefits in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease
- Researchers Suggest Possible Biomarker for Diabetic Cardiomyopathy
The deadline is coming up for the Endocrine Fellows Series: Osteoporosis and Metabolic Bone Diseases, being held August 1-2, 2018 in Santa Fe, New Mexico. Apply by May 17.
Early Registration is now open for Endocrine Board Review 2018 taking place September 4–5 in Miami, Florida.
Clinical Endocrinology Update (CEU) will provide you with the opportunity to learn from and network with faculty at the forefront of endocrine practice and research. Early Registration is now open for:
Become a member today to join our global community of 18,000 members dedicated to advancing hormone science and medicine to improve health worldwide.
The Endocrine Society’s guideline app is your source for 35 interactive clinical tools derived from the content of 12 of the Society’s guidelines, as well as guideline recommendations, information for patients, and clinician education modules.
Negative allosteric modification of 17β-estradiol binding to estrogen receptor β by 27-hydroxycholesterol was identified and verified by analysis of various types of receptor-ligand binding assays.
Inhibiting Cellular Senescence: A New Therapeutic Paradigm for Age-Related Osteoporosis
Cellular senescence is an aging mechanism that contributes to age-related osteoporosis and other age-associated diseases. Targeting this pathway could simultaneously treat multiple aging morbidities.
Evaluating Causality of Gut Microbiota in Obesity and Diabetes in Humans
We have reviewed the evidence of the gut microbiome as a driving force in the development of obesity and type 2 diabetes mellitus. Considering overlap in potential mechanisms, the role of the gut microbiome in type 1 diabetes mellitus will also be addressed.
Testosterone and All-Cause Mortality in Older Men: The Role of Metabolic Syndrome
We evaluated the association of testosterone with mortality in men and found metabolic syndrome (MetS) was an effect modifier of this relationship. Low testosterone increased mortality among men with MetS.